Another week in the bank. Here are my picks for the top five stories of the week: Hospitals Adopt Drug Industry Sales Strategy. Hospitals are starting to sell themselves using ole’ pharma tactics! Plaintiffs Win Key Ruling On Preemption In Metoclopramide Mass Tort Litigation. A state trial judge in Philadelphia has denied generic drug manufacturers’ [...]
Pfizer Smacked With $72.6 Million In Damages In Breast Cancer Case
Dec. 6 (Bloomberg) — Pfizer Inc. must pay $72.6 million in damages to three women who said they developed breast cancer after taking the company’s menopause drugs, a Philadelphia jury decided. Jurors today in state court deliberated over two days before finding hormone-replacement drugs made by Pfizer’s Wyeth and Pharmacia Upjohn units were responsible for [...]
No Generic Drug Preemption For “Dear Doctor” Letters
A Nevada State Court Judge ruled that plaintiffs can sue generic drug manufacturers despite the Supreme Court’s recent ruling protecting drug companies from lawsuits in PLIVA, Inc. v. Mensing
Welcome To The Bark
The Bark is the blog of Mark Sadaka. Mark is the founder of Law Offices of Sadaka Associates LLC, advocate and scientist.
Topics
Why Mark Sadaka?
Selected for the inclusion in the 2011 New York Metro Area Rising Star list, Mark Sadaka is recognized by his peers as a top litigator. He has handled hundreds of cases for victims of toxic substances, pharmaceuticals and medical devices.
Mark Sadaka is dedicated to pursuing your case diligently so that you receive the compensation you deserve in a timely manner. And he is committed to working with you in a ethical, helpful and compassionate manner.
Twitter Stream
Follow @MarkSadaka on Twitter





